Cislini Jeff 4
4 · Revolution Medicines, Inc. · Filed Oct 20, 2025
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2025-10-17$36.57/sh+12,000$438,840→ 62,425 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-17−12,000→ 18,000 totalExercise: $36.57From: 2024-06-15Exp: 2030-06-16→ Common Stock (12,000 underlying) - Sale
Common Stock
2025-10-17$55.00/sh−12,000$660,000→ 50,425 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.
- [F2]Includes 43,910 restricted stock units.